CMS to provide Medicare Part D beneficiaries with $50 monthly access to certain GLP-1 medications
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible Medicare Part D beneficiaries for $50 per month beginning July 1 this year through Dec. 31, 2027. The program will be conducted under the agency’s short-term demonstration, the Medicare GLP-1 Bridge. The demonstration is tied to CMS’ Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth Model, or BALANCE, which is designed to increase access to GLP-1 medications and other healthy lifestyle interventions.
Related News Articles
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The AHA today submitted comments on the Centers for Medicare & Medicaid Services’ proposed revisions to Medicare Advantage and Part D reporting…
Headline
The Centers for Medicare & Medicaid Services has begun collecting private payor rate data through its Fee-for-Service Data Collection System Clinical Lab…
Headline
Sens. Chuck Grassley, R-Iowa, and Michael Bennet, D-Colo., April 30 introduced the Rural Community Hospital Demonstration Reauthorization Act, legislation that…
Headline
The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to expedite access to certain FDA-…
Blog
In think‑tank reports, like the one released this week by Paragon Health Institute, hospitals are often reduced to abstractions — payment rates, charts,…